Use of wavelet and fast fourier transforms in pharmacodynamics

Journal of Pharmacology and Experimental Therapeutics

Volumn 321, Issue 2, 2007, Pages 423-430

  Mager, Donald E ^a   Abernethy, Darrell R ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL RHYTHM; FOURIER TRANSFORMATION; IMAGE PROCESSING; MATHEMATICAL ANALYSIS; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPECTROSCOPY; WAVELET ANALYSIS;

ANIMALS; FOURIER ANALYSIS; HEART RATE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MATHEMATICS; PHARMACOLOGY; SIGNAL PROCESSING, COMPUTER-ASSISTED; SIGNAL TRANSDUCTION;

EID: 34247224388     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.113183     Document Type: Review

References (61)

1. Aderem A (2005) Systems biology: its practice and challenges. Cell 121:511-513.
2. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, and Cohen RJ (1981) Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science (Wash DC) 213:220-222.
3. Alcalay M, Izraeli S, Wallach-Kapon R, Tochner Z, Benjamini Y, and Akselrod S (1992) Paradoxical pharmacodynamic effect of atropine on parasympathetic control: a study by spectral analysis of heart rate fluctuations. Clin Pharmacol Ther 52:518-527.
4. Aston JA, Gunn RN, Hinz R, and Turkheimer FE (2005) Wavelet variance components in image space for spatiotemporal neuroimaging data. Neuroimage 25:159-168.
5. Black JW and Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci 220:141-162.
6. Bork P and Serrano L (2005) Towards cellular systems in 4D. Cell 121:507-509.
7. Brigham EO (1988) The Fast Fourier Transform and its Applications. Prentice-Hall, Inc., Upper Saddle River, NJ.
8. Bullmore E, Fadili J, Maxim V, Sendur L, Whitcher B, Suckling J, Brammer M, and Breakspear M (2004) Wavelets and functional magnetic resonance imaging of the human brain. Neuroimage 23 (Suppl 1):S234-S249.
9. Craft N and Schwartz JB (1995) Effects of age on intrinsic heart rate, heart rate variability, and AV conduction in healthy humans. Am J Physiol 268:H1441-H1452.
10. Danhof M (2002) Electroencephalography parameters as biomarkers: extrapolation from laboratory animals to humans. Methods Find Exp Clin Pharmacol 24 (Suppl D):63-64.
11. Daubechies I (1992) Ten Lectures on Wavelets. SIAM, Philadelphia.
12. Dokoumetzidis A, Iliadis A, and Macheras P (2001) Nonlinear dynamics and chaos theory: Concepts and applications relevant to pharmacodynamics. Pharm Res (NY) 18:415-426.
13. Eungdamrong NJ and Iyengar R (2004) Computational approaches for modeling regulatory cellular networks. Trends Cell Biol 14:661-669.
14. Gabor D (1946) Theory of communication J Inst Elec Eng 93:429-457.
15. Goldberger AL, Amaral LAN, Hausdorff JM, Ivanov PC, and Peng CK (2002) Fractal dynamics in physiology: Alterations with disease and aging. Proc Natl Acad Sci 99:2466-2472.
16. Gorbunova YV and Spitzer NC (2002) Dynamic interactions of cyclic AMP transients and spontaneous Ca(2+) spikes. Nature (Lond) 418:93-96.
17. Gueorguieva I, Nestorov IA, and Rowland M (2005) Reducing whole body physiologically based pharmacokinetic models using global sensitivity analysis: Diazepam case study. J Pharmacokinet Pharmacodyn 33:1-27.
18. Hayano J, Sakakibara Y, Yamada M, Kamiya T, Fujinami T, Yokoyama K, Watanabe Y, and Takata K (1990) Diurnal variations in vagal and sympathetic cardiac control. Am J Physiol 258:H642-H646.
19. Holcman D and Schuss Z (2005) Stochastic chemical reactions in microdomains. J Chem Phys 122:114710-114715.
20. Ivanov PC, Rosenblum MG, Peng CK, Mietus J, Havlin S, Stanley HE, and Goldberger AL (1996) Scaling behaviour of heartbeat intervals obtained by wavelet-based time-series analysis. Nature (Lond) 383:323-327.
21. Joho S, Asanoi H, Remah HA, Igawa A, Kameyama T, Nozawa T, Umeno K, and Inoue H (1999) Time-varying spectral analysis of heart rate and left ventricular pressure variability during balloon coronary occlusion in humans: a sympathoexicitatory response to myocardial ischemia. J Am Coll Cardiol 34:1924-1931.
22. Kenworthy AK (2001) Imaging protein-protein interactions using fluorescence resonance energy transfer microscopy. Methods 24:289-296.
23. Kobrinsky E, Mager DE, Bentil SA, Murata S, Abernethy DR, and Soldatov NM (2005) Identification of plasma membrane macro- and microdomains from wavelet analysis of FRET microscopy. Biophys J 88:3625-3634.
24. Krzyzanski W, Chakraborty A, and Jusko WJ (2000) Algorithm for application of Fourier analysis for biorhythmic baselines of pharmacodynamic indirect response models. Chronobiol Int 17:77-93.
25. Kunkel MT, Ni Q, Tsien RY, Zhang J, and Newton AC (2005) Spatio-temporal dynamics of protein kinase B/Akt signaling revealed by a genetically encoded fluorescent reporter. J Biol Chem 280:5581-5587.
26. Laine AF (2000) Wavelets in temporal and spatial processing of biomedical images. Annu Rev Biomed Eng 2:511-550.
27. Liao D, Cai J, Rosamond WD, Barnes RW, Hutchinson RG, Whitsel EA, Rautaharju P, and Heiss G (1995) Cardiac autonomic function and incident coronary heart disease - The ARIC Study. Circulation 92:418.
28. Mager DE and Jusko WJ (2001) Pharmacodynamic modeling of time-dependent transduction systems. Clin Pharmacol Ther 70:210-216.
29. Mager DE, Lin SX, Blum RA, Lates CD, and Jusko WJ (2003) Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics. J Clin Pharmacol 43:1216-1227.
30. Mainardi LT, Bianchi AM, and Cerutti S (2002) Time-frequency and time-varying analysis for assessing the dynamic responses of cardiovascular control. Crit Rev Biomed Eng 30:175-217.
31. Malliani A, Pagani M, Lombardi F, and Cerutti S (1991) Cardiovascular neural regulation explored in the frequency domain. Circulation 84:482-492.
32. Mandema JW and Danhof M (1992) Electroencephalogram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs. Clin Pharmacokinet 23:191-215.
33. Millet P, Ibanez V, Delforge J, Pappata S, and Guimon J (2000) Wavelet analysis of dynamic PET data: application to the parametric imaging of benzodiazepine receptor concentration. Neuroimage 11:458-472.
34. Novak V, Novak P, and Low PA (1997) Time-frequency analysis of cardiovascular function and its clinical implications, in Clinical Autonomic Disorders (Low PA ed), pp 323-348, Lippincott-Raven Publishers, Philadelphia.
35. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S, Piccaluga E, et al. (1986) Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 59:178-193.
36. Perlstein I and Hoffman A (2000) Cumulative plot of heart rate variability spectrum assesses kinetics of action cholinergic drugs in rats. Am J Physiol 279:H110-H115.
37. Perlstein I, Stepensky D, Krzyzanski W, and Hoffman A (2002) A signal transduction pharmacodynamic model of the kinetics of the parasympathomimetic activity of low-dose scopolamine and atropine in rats. J Pharm Sci 91:2500-2510.
38. Perlstein I, Stepensky D, Sapoznikov D, and Hoffman A (2001) Power spectral analysis of heart rate variability in rats as a quantitative tool in the pk-pd analysis of the parasympatholytic activity of atropine. Pharm Res (NY) 18:1220-1225.
39. Petersen NO, Hoddelius PL, Wiseman PW, Seger O, and Magnusson KE (1993) Quantitation of membrane receptor distributions by image correlation spectroscopy: Concept and application. Biophys J 65:1135-1146.
40. Press WH, Teukolsky SA, Vetterling WT, and Flannery BP (1992) Numerical Recipes in Fortran 77. The Art of Scientific Computing. University Press, Cambridge.
41. Scheinin H, Helminen A, Huhtala S, Gronroos P, Bosch JA, Kuusela T, Kanto J, and Kaila T (1999) Spectral analysis of heart rate variability as a quantitative measure of parasympatholytic effect-integrated pharmacokinetics and pharmacodynamics of three anticholinergic drugs. Ther Drug Monit 21:141-151.
42. Semmlow JL (2004) Biosignal and Biomedical Image Processing. Marcel Dekker, Inc., New York.
43. Siegel RA and Ramanathan M (2005) Commentary: Stochastic phenomena in pharmacokinetic, pharmacodynamic, and pharmacogenomic models. AAPS J 7:E141-E142.
44. Sosnovtseva OV, Pavlov AN, Brazhe NA, Brazhe AR, Erokhova LA, Maksimov GV, and Mosekilde E (2005a) Interference microscopy under double-wavelet analysis: a new approach to studying cell dynamics. Phys Rev Lett 94:218103.
45. Sosnovtseva OV, Pavlov AN, Mosekilde E, Holstein-Rathlou NH, and Marsh DJ (2005b) Double-wavelet approach to studying the modulation properties of nonstationary multimode dynamics. Physiol Meas 26:351-362.
46. Tallarida RJ (1990) On stability and control of ligand-receptor interactions according to the mass action law: a theoretical model of chaos. Drug Dev Res 19:257-274.
47. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation 93:1043-1065.
48. Thayer JF, Merritt MM, Sollers JJ 3rd, Zonderman AB, Evans MK, Yie S, and Abernethy DR (2003) Effect of angiotensin-converting enzyme insertion/deletion polymorphism DD genotype on high-frequency heart rate variability in African Americans. Am J Cardiol 92:1487-1490.
49. Toledo E, Gurevitz O, Hod H, Eldar M, and Akselrod S (2003) Wavelet analysis of instantaneous heart rate: a study of autonomic control during thrombolysis. Am J Physiol 284:R1079-R1091.
50. Turkheimer FE, Banati RB, Visvikis D, Aston JA, Gunn RN, and Cunningham VJ (2000) Modeling dynamic PET-SPECT studies in the wavelet domain. J Cereb Blood Flow Metab 20:879-893.
51. van Rossum JM and de Bie JEGM (1991) Chaos and illusion. Trends Pharmacol Sci 12:379-383.
52. A receptor modulators: in vitro-in vivo correlations. J Pharmacol Exp Ther 304:88-101.
53. Welzig CM, Shin DG, Park HJ, Kim YJ, Saul JP, and Galper JB (2003) Lipid lowering by pravastatin increases parasympathetic modulation of heart rate. Circulation 108:2743-2746.
54. Weng G, Bhalla US, and Iyengar R (1999) Complexity in biological signaling systems. Science (Wash DC) 284:92-96.
55. Whitcher B, Schwarz AJ, Barjat H, Smart SC, Grundy RI, and James MF (2005) Wavelet-based cluster analysis: data-driven grouping of voxel time courses with application to perfusion-weighted and pharmacological MRI of the rat brain. Neuroimage 24:281-295.
56. Wiklund U, Akay M, and Niklasson U (1997) Short-term analysis of heart-rate variability by adapted wavelet transforms. IEEE Eng Med Biol Mag 16:113-118, 138.
57. Wiseman PW, Brown CM, Webb DJ, Hebert B, Johnson NL, Squier JA, Ellisman MH, and Horwitz AF (2004) Spatial mapping of integrin interactions and dynamics during cell migration by image correlation microscopy. J Cell Sci 117:5521-5534.
58. Wiseman PW and Petersen NO (1999) Image correlation spectroscopy. II. Optimization for ultrasensitive detection of pre-existing platelet-derived growth factorbeta receptor oligomers on intact cells. Biophys J 76:963-977.
59. Yao Z, DuBois DC, Almon RR, and Jusko WJ (2006) Modeling circadian rhythms of glucocorticoid receptor and glutamine synthetase expression in rat skeletal muscle. Pharm Res (NY) 23:670-679.
60. Zhang L, Zhang A, and Ramanathan M (2003) Fourier harmonic approach for visualizing temporal patterns of gene expression data. Proc IEEE Comput Soc Bioinform Conf 2:137-147.
61. Zhang L, Zhang A, and Ramanathan M (2004) VizStruct: exploratory visualization for gene expression profiling. Bioinformatics 20:85-92.